116 related articles for article (PubMed ID: 17521577)
1. The hyper IgE syndrome and mutations in TYK2.
Woellner C; Schäffer AA; Puck JM; Renner ED; Knebel C; Holland SM; Plebani A; Grimbacher B
Immunity; 2007 May; 26(5):535; author reply 536. PubMed ID: 17521577
[No Abstract] [Full Text] [Related]
2. Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome.
Kreins AY; Ciancanelli MJ; Okada S; Kong XF; Ramírez-Alejo N; Kilic SS; El Baghdadi J; Nonoyama S; Mahdaviani SA; Ailal F; Bousfiha A; Mansouri D; Nievas E; Ma CS; Rao G; Bernasconi A; Sun Kuehn H; Niemela J; Stoddard J; Deveau P; Cobat A; El Azbaoui S; Sabri A; Lim CK; Sundin M; Avery DT; Halwani R; Grant AV; Boisson B; Bogunovic D; Itan Y; Moncada-Velez M; Martinez-Barricarte R; Migaud M; Deswarte C; Alsina L; Kotlarz D; Klein C; Muller-Fleckenstein I; Fleckenstein B; Cormier-Daire V; Rose-John S; Picard C; Hammarstrom L; Puel A; Al-Muhsen S; Abel L; Chaussabel D; Rosenzweig SD; Minegishi Y; Tangye SG; Bustamante J; Casanova JL; Boisson-Dupuis S
J Exp Med; 2015 Sep; 212(10):1641-62. PubMed ID: 26304966
[TBL] [Abstract][Full Text] [Related]
3. Compound heterozygous TYK2 mutations underlie primary immunodeficiency with T-cell lymphopenia.
Nemoto M; Hattori H; Maeda N; Akita N; Muramatsu H; Moritani S; Kawasaki T; Maejima M; Ode H; Hachiya A; Sugiura W; Yokomaku Y; Horibe K; Iwatani Y
Sci Rep; 2018 May; 8(1):6956. PubMed ID: 29725107
[TBL] [Abstract][Full Text] [Related]
4. Clinical manifestations of hyper IgE syndromes.
Freeman AF; Holland SM
Dis Markers; 2010; 29(3-4):123-30. PubMed ID: 21178271
[TBL] [Abstract][Full Text] [Related]
5. Hyper-immunoglobulin E-like syndrome in a patient with multiple genetic mutations.
Akenroye AT; Iammatteo M; de Vos GS
Ann Allergy Asthma Immunol; 2017 May; 118(5):643-644. PubMed ID: 28366583
[No Abstract] [Full Text] [Related]
6. A New Patient with Inherited TYK2 Deficiency.
Sarrafzadeh SA; Mahloojirad M; Casanova JL; Badalzadeh M; Bustamante J; Boisson-Dupuis S; Pourpak Z; Nourizadeh M; Moin M
J Clin Immunol; 2020 Jan; 40(1):232-235. PubMed ID: 31713088
[No Abstract] [Full Text] [Related]
7. [Hyper-IgE syndromes].
He YY; Liu B; Xiao XP
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(11):892-896. PubMed ID: 29775011
[TBL] [Abstract][Full Text] [Related]
8. Novel mutations of TYK2 leading to divergent clinical phenotypes.
Lv G; Sun G; Wu P; Du X; Zeng T; Wen W; Zhou L; An Y; Tang X; He T; Zhao X; Du H
Pediatr Allergy Immunol; 2022 Jan; 33(1):e13671. PubMed ID: 34569645
[TBL] [Abstract][Full Text] [Related]
9. Primary Immunodeficiencies with Elevated IgE.
Mogensen TH
Int Rev Immunol; 2016; 35(1):39-56. PubMed ID: 25970001
[TBL] [Abstract][Full Text] [Related]
10. Impaired IL-23-dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency.
Ogishi M; Arias AA; Yang R; Han JE; Zhang P; Rinchai D; Halpern J; Mulwa J; Keating N; Chrabieh M; Lainé C; Seeleuthner Y; Ramírez-Alejo N; Nekooie-Marnany N; Guennoun A; Muller-Fleckenstein I; Fleckenstein B; Kilic SS; Minegishi Y; Ehl S; Kaiser-Labusch P; Kendir-Demirkol Y; Rozenberg F; Errami A; Zhang SY; Zhang Q; Bohlen J; Philippot Q; Puel A; Jouanguy E; Pourmoghaddas Z; Bakhtiar S; Willasch AM; Horneff G; Llanora G; Shek LP; Chai LYA; Tay SH; Rahimi HH; Mahdaviani SA; Nepesov S; Bousfiha AA; Erdeniz EH; Karbuz A; Marr N; Navarrete C; Adeli M; Hammarstrom L; Abolhassani H; Parvaneh N; Al Muhsen S; Alosaimi MF; Alsohime F; Nourizadeh M; Moin M; Arnaout R; Alshareef S; El-Baghdadi J; Genel F; Sherkat R; Kiykim A; Yücel E; Keles S; Bustamante J; Abel L; Casanova JL; Boisson-Dupuis S
J Exp Med; 2022 Oct; 219(10):. PubMed ID: 36094518
[TBL] [Abstract][Full Text] [Related]
11. Human tyk2 kinase deficiency: another primary immunodeficiency syndrome.
Watford WT; O'Shea JJ
Immunity; 2006 Nov; 25(5):695-7. PubMed ID: 17098200
[TBL] [Abstract][Full Text] [Related]
12. Tyk2 mutation homologous to V617F Jak2 is not found in essential thrombocythaemia, although it induces constitutive signaling and growth factor independence.
Shide K; Shimoda K; Kamezaki K; Kakumitsu H; Kumano T; Numata A; Ishikawa F; Takenaka K; Yamamoto K; Matsuda T; Harada M
Leuk Res; 2007 Aug; 31(8):1077-84. PubMed ID: 17011030
[TBL] [Abstract][Full Text] [Related]
13. A patient with tyrosine kinase 2 deficiency without hyper-IgE syndrome.
Kilic SS; Hacimustafaoglu M; Boisson-Dupuis S; Kreins AY; Grant AV; Abel L; Casanova JL
J Pediatr; 2012 Jun; 160(6):1055-7. PubMed ID: 22402565
[TBL] [Abstract][Full Text] [Related]
14. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity.
Minegishi Y; Saito M; Morio T; Watanabe K; Agematsu K; Tsuchiya S; Takada H; Hara T; Kawamura N; Ariga T; Kaneko H; Kondo N; Tsuge I; Yachie A; Sakiyama Y; Iwata T; Bessho F; Ohishi T; Joh K; Imai K; Kogawa K; Shinohara M; Fujieda M; Wakiguchi H; Pasic S; Abinun M; Ochs HD; Renner ED; Jansson A; Belohradsky BH; Metin A; Shimizu N; Mizutani S; Miyawaki T; Nonoyama S; Karasuyama H
Immunity; 2006 Nov; 25(5):745-55. PubMed ID: 17088085
[TBL] [Abstract][Full Text] [Related]
15. Hyper-IgE syndrome with a novel mutation of the STAT3 gene.
Minakawa S; Tanaka H; Kaneko T; Matsuzaki Y; Kono M; Akiyama M; Minegishi Y; Sawamura D
Clin Exp Dermatol; 2016 Aug; 41(6):687-9. PubMed ID: 27333819
[No Abstract] [Full Text] [Related]
16. Hyper-IgE syndrome.
Rezaei N; Aghamohammadi A
J Postgrad Med; 2010; 56(2):63-4. PubMed ID: 20622381
[No Abstract] [Full Text] [Related]
17. Hyper-IgE syndrome.
Minegishi Y
Curr Opin Immunol; 2009 Oct; 21(5):487-92. PubMed ID: 19717292
[TBL] [Abstract][Full Text] [Related]
18. STAT3 mutations in the hyper-IgE syndrome.
Holland SM; DeLeo FR; Elloumi HZ; Hsu AP; Uzel G; Brodsky N; Freeman AF; Demidowich A; Davis J; Turner ML; Anderson VL; Darnell DN; Welch PA; Kuhns DB; Frucht DM; Malech HL; Gallin JI; Kobayashi SD; Whitney AR; Voyich JM; Musser JM; Woellner C; Schäffer AA; Puck JM; Grimbacher B
N Engl J Med; 2007 Oct; 357(16):1608-19. PubMed ID: 17881745
[TBL] [Abstract][Full Text] [Related]
19. Cerebral aneurysm in a 12-year-old boy with a STAT3 mutation (hyper-IgE syndrome).
Kim Y; Nard JA; Saad A; Casselman J; Wessell KR; Toller-Artis E; Tcheurekdijan H; Hostoffer RW
Ann Allergy Asthma Immunol; 2015 May; 114(5):430-1. PubMed ID: 25814298
[No Abstract] [Full Text] [Related]
20. The Seven STAT3-Related Hyper-IgE Syndromes.
Fadil I; Ben-Ali M; Jeddane L; Barbouche MR; Bousfiha AA
J Clin Immunol; 2021 Aug; 41(6):1384-1389. PubMed ID: 33903995
[No Abstract] [Full Text] [Related]
[Next] [New Search]
